BIT
KYTH

BlackRock Institutional Trust’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

BlackRock Institutional Trust’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-556,157
Closed -$41.7M – 4063
2015
Q3 		$41.7M Buy
556,157
+79,455
+17% +$5.93M 0.01% 1332
2015
Q2 		$35.9M Sell
476,702
-178,671
-27% -$9.57M 0.01% 1509
2015
Q1 		$32.9M Buy
655,373
+412,948
+170% +$17.3M 0.01% 1598
2014
Q4 		$8.41M Buy
242,425
+56,590
+30% +$1.97M ﹤0.01% 2461
2014
Q3 		$6.09M Sell
185,835
-12,455
-6% -$439K ﹤0.01% 2599
2014
Q2 		$7.61M Buy
198,290
+53,507
+37% +$1.87M ﹤0.01% 2584
2014
Q1 		$5.76M Buy
144,783
+4,483
+3% +$201K ﹤0.01% 2730
2013
Q4 		$5.24M Buy
140,300
+18,529
+15% +$769K ﹤0.01% 2760
2013
Q3 		$5.55M Buy
121,771
+2,663
+2% +$79.6K ﹤0.01% 2681
2013
Q2 		$3.22M Buy
+119,108
New +$2.73M ﹤0.01% 2885

BlackRock Institutional Trust's KYTH Position: Q4 2015 in Review

BlackRock Institutional Trust sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 556,157 shares — an estimated $41.7M sold.

BlackRock Institutional Trust first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $41.7M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • BlackRock Institutional Trust reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • BlackRock Institutional Trust sold 556,157 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $41.7M.
  • BlackRock Institutional Trust first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
  • BlackRock Institutional Trust's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $41.7M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on BlackRock Institutional Trust's 13F filing for Q4 2015, filed 11 Feb 2016.